ArticleCurrent oncology (Toronto, Ont.)2021

Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study.

Fabian Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.